« Back

Akihisa Mori, Ph.D., was appointed a member of the Board of Directors and R&D Head of SNLD Ltd., right after he joined the company in October 2022. Prior to joining SNLD Ltd., Dr. Mori was employed by Kyowa Kirin Co., Ltd. from April 1985 to March 2022, most recently as a Fellow. At Kyowa Kirin Co., Ltd., he began his career as a neuroscientist in the research lab and then transitioned into clinical development and global project leadership, serving in its US offices between 2008 and 2010 in Princeton, NJ, working on global portfolio strategy and global medical affairs. He has been specialized entirely in Parkinson’s disease and the neurology area, achieving marketing approval of a first-in class antiparkinsonian product in the US and Japan. Dr. Mori received a B.S. from the Faculty of Pharmaceutical Sciences at Kyoto University and holds a Ph.D. from the Graduate School of Medicine at the University of Tokyo.